H2 Equity Partners portfolio company Healthcare 21 has acquired Xograph Healthcare and Cardio Solutions

Healthcare 21 (“HC21”) acquired Xograph Healthcare (“Xograph”) in December 2019, which distributes and services specialist X-Ray devices and Cardio Solutions (“CS”) in March 2020, a leading distributor of specialist cardiothoracic products.

The combined HC21 Group now has revenues in excess of €155 million employing c430 FTE with operations focused on the UK and Ireland. The Group has a leading product range in the healthcare market supported by a strong and growing service division.

The acquisition of Xograph and CS has strengthened the core propositions in both the X-Ray and service market as well as adding a specialised cardiothoracic product portfolio and team to the business. These acquisitions are a further step towards achieving the strategic vision for the group to be the clear market leader in healthcare distribution and service across the geographies it operates in.

Xograph, founded in 1967 and based in Stonehouse, is the largest independent medical imaging equipment supplier throughout the UK and Ireland serving NHS and HSE hospitals, private hospitals, clinics and diagnostic centres. It provides innovative medical imaging technology, supported by a nationwide team of highly trained field-based engineers and clinical applications specialists.

Cardio Solutions, founded in 2005, is a specialised supplier of cardiothoracic products throughout the UK and Ireland. The business provides market leading niche products predominately to the specialist cardiothoracic centres.

For further information of Healthcare 21, please visit www.healthcare21.eu. For more information on Xograph please visit www.xograph.com and for Cardio Solutions visit www.cardiosolutions.co.uk